Novartis AG (NVS)
158.02
-0.84
(-0.53%)
USD |
NYSE |
Aug 24, 16:00
158.00
-0.02
(-0.01%)
After-Hours: 20:00
Novartis Market Cap : 289.26B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 289.26B |
| August 21, 2026 | 290.80B |
| August 20, 2026 | 286.00B |
| August 19, 2026 | 293.46B |
| August 18, 2026 | 282.91B |
| August 17, 2026 | 278.19B |
| August 14, 2026 | 276.19B |
| August 13, 2026 | 277.73B |
| August 12, 2026 | 278.83B |
| August 11, 2026 | 283.02B |
| August 10, 2026 | 287.01B |
| August 07, 2026 | 286.17B |
| August 06, 2026 | 282.29B |
| August 05, 2026 | 282.71B |
| August 04, 2026 | 280.57B |
| August 03, 2026 | 281.30B |
| July 31, 2026 | 285.84B |
| July 30, 2026 | 290.03B |
| July 29, 2026 | 290.75B |
| July 28, 2026 | 292.61B |
| July 27, 2026 | 285.77B |
| July 24, 2026 | 283.75B |
| July 23, 2026 | 285.82B |
| July 22, 2026 | 280.22B |
| July 21, 2026 | 281.67B |
| Date | Value |
|---|---|
| July 20, 2026 | 273.78B |
| July 17, 2026 | 281.47B |
| July 16, 2026 | 291.42B |
| July 15, 2026 | 287.74B |
| July 14, 2026 | 286.90B |
| July 13, 2026 | 292.64B |
| July 10, 2026 | 293.94B |
| July 09, 2026 | 295.03B |
| July 08, 2026 | 296.08B |
| July 07, 2026 | 299.63B |
| July 06, 2026 | 296.69B |
| July 02, 2026 | 305.10B |
| July 01, 2026 | 294.11B |
| June 30, 2026 | 299.04B |
| June 29, 2026 | 300.70B |
| June 26, 2026 | 296.54B |
| June 25, 2026 | 295.98B |
| June 24, 2026 | 292.17B |
| June 23, 2026 | 292.66B |
| June 22, 2026 | 284.17B |
| June 18, 2026 | 280.64B |
| June 17, 2026 | 287.89B |
| June 16, 2026 | 287.99B |
| June 15, 2026 | 289.19B |
| June 12, 2026 | 292.07B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 317.27B |
| AstraZeneca PLC | 517.08B |
| Johnson & Johnson | 657.54B |
| Eli Lilly & Co. | 1.174T |
| Merck & Co., Inc. | 371.93B |
Market Cap Related Metrics
| PE Ratio | 23.84 |
| PS Ratio | 5.551 |
| Price to Book Value | 6.963 |
| Price to Free Cash Flow | 20.29 |
| Price | 158.02 |
| Earnings Yield | 4.19% |
| Operating PE Ratio | 18.77 |
| Normalized PE Ratio | 22.21 |